• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Epidemiology of respiratory viruses according to age group, 2023-24 winter season, Kyoto, Japan

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Jan 6;15(1):924.
doi: 10.1038/s41598-024-85068-7. Epidemiology of respiratory viruses according to age group, 2023-24 winter season, Kyoto, Japan

Yasufumi Matsumura[SUP] 1 [/SUP], Masaki Yamamoto[SUP] 2 [/SUP], Yusuke Tsuda[SUP] 2 [/SUP], Koh Shinohara[SUP] 2 [/SUP], Yasuhiro Tsuchido[SUP] 2 [/SUP], Satomi Yukawa[SUP] 2 [/SUP], Taro Noguchi[SUP] 2 [/SUP], Kazuo Takayama[SUP] 3 [/SUP], Miki Nagao[SUP] 2 [/SUP]



Affiliations
Abstract

The seasonality and epidemiology of viral acute respiratory infections (ARIs) have changed since the coronavirus disease 2019 pandemic. However, molecular-based ARI surveillance has not been conducted in Japan. We developed a regional surveillance program to define the local epidemiology of ARIs. Between December 2023 and March 2024, 2,992 upper respiratory samples collected from patients suspected of having ARIs at five facilities in Kyoto City, Japan, were tested for SARS-CoV-2, influenza virus, and respiratory syncytial virus (RSV) using RT‒PCR. Samples negative for these viruses were randomly selected for testing with the FilmArray Respiratory Panel, and the detection rates of other viruses were estimated. SARS-CoV-2, influenza virus, and RSV were detected in 598 (20.3%), 165 (5.6%), and 40 (1.4%) of the 2,949 samples with valid RT‒PCR results, respectively. The most prevalent viruses in the < 6, 6-17, 18-64, and ≥ 65 year age groups were rhinovirus/enterovirus, RSV, and SARS-CoV-2; influenza virus, seasonal coronavirus, and rhinovirus/enterovirus; SARS-CoV-2, seasonal coronavirus, and influenza virus; and SARS-CoV-2, seasonal coronavirus, and influenza virus, respectively. Significant differences in the detection rates of these viruses were detected between the age groups. This study highlights the importance of age-stratified molecular-based surveillance for a comprehensive understanding of the epidemiology of ARIs.

Keywords: Epidemiology; Molecular diagnostics; Respiratory viruses; Surveillance.

 
Back
Top Bottom